Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10872966 | FEBS Letters | 2005 | 8 Pages |
Abstract
The abnormal hyperphosphorylation of tau protein is one of the hallmarks of Alzheimer disease and other tauopathies; as yet the exact role of various tau kinases in this pathology is not fully understood. Here, we show that injection of isoproterenol, an activator of cAMP-dependent kinase (PKA), into rat hippocampus bilaterally results in the activation of PKA, calcium/calmodulin-dependent kinase II and cyclin-dependent kinase-5, inhibition of protein phosphatase-2A, hyperphosphorylation of tau at several Alzheimer-like epitopes and a disturbance of spatial memory retention 48 h after the drug injection. These findings suggest the involvement of PKA and PKA-mediated signaling pathway in the Alzheimer-like tau hyperphosphorylation and memory impairment.
Keywords
CREBanterior to posteriorAKAP79cAMP-dependent kinasePP-2AGSK-3FTDP-17Cdk-5PKCpKaDABPBSCaMKIIMAPKisoproterenolAlzheimer diseaseAlzheimer’s diseaselong-term potentiationLTPdiaminobenzidinefrontotemporal dementia with Parkinsonism linked to chromosome 17normal salinecyclin-dependent kinase-5Phosphate-buffered salineTau hyperphosphorylationcAMP-responsive element binding proteinProtein phosphatase-2Acalcium/calmodulin-dependent protein kinase IIProtein kinase Cmitogen-activated protein kinasecAMP-dependent protein kinasecalcium/calmodulin-dependent kinase IINormal controlglycogen synthase kinase-3
Related Topics
Life Sciences
Agricultural and Biological Sciences
Plant Science
Authors
Li Sun, XiaoChuang Wang, Shengyuan Liu, Quan Wang, JianZhi Wang, Malika Bennecib, Cheng-Xin Gong, Amitabha Sengupta, Inge Grundke-Iqbal, Khalid Iqbal,